Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care 23:23–29, 2000
Gaynes BN, Burns B, Tweed D, Erickson P: Depression and health-related quality of life. J Nerv Ment Dis 190:799–806, 2002
Golden SH, Williams JE, Ford DE, Yeh H, Sanford CP, Nieto FJ, Brancati FL: Depressive symptoms and the risk of type 2 diabetes. Diabetes Care 27:429–435, 2004
Goodnick PJ, Kumar A, Henry JH, Buki VM, Goldberg RB: Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull 33:261–264, 1997
Grandinetti A, Kaholokula J, Crabbe K, Kenui C, Chen R, Chang H: Relationship between depressive symptoms and diabetes among native Hawaiians. Psychoneuroendocrinology 25:239–246, 2000
Grey M, Whittemore R, Tamborlane W: Depression in type 1 diabetes children: natural history and correlates. J Psychosom Res 53:907–911, 2002
Gross R, Olfson M, Gameroff M, Carasquillo O, Shea S, Feder A, Lantigua R, Fuentes M, Weissman M: Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med 20:460–466, 2004
Gulseren L, Gulseren S, Hekimsoy Z, Mete L: Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Arch Med Res 36:159–165, 2005
Helzer JE, Robins LN: The Diagnostic Interview Schedule: its development, evolution and use. Soc Psychiatry Psychiatr Epidemiol 23:6–16, 1988
Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T: How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 49:469–477, 2006
Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M: A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care 30:1473–1479, 2007
Jacobson AM, de Groot M, Samson JA: The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus. Qual Life Res 6:11–20, 1997a
Jacobson AM, Hauser ST, Willet JB, Wolfsdorf JI, Dvorak R, Herman L, de Groot M: Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care 20:811–818, 1997b
Jones LE, Clarke W, Carney CP: Receipt of diabetes services by insured adults with and without claims for mental disorders. Medical Care 42:1167–1175, 2004
Katon W, Lin EHB, Kroenke K: The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry 29:147–155, 2007
Katon W, Unutzer J, Fan M, Williams JW, Schoenbaum M, Lin EHB, Hunkeller EM: Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 29:265–270, 2006
Katon W, Rutter C, Simon G, Lin EB, Ludman E, Ciechanowski P, Kinder L, Young G, von Korff M: The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28:2668–2672, 2005
Katon W, Simon G, Russo J, von Korff M, Lin E, Ludman E, Ciechanowski P, Bush T: Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care 42:1222–1229, 2004a
Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B: Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914–920, 2004b
Katon W, Von Korff M, Lin E, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T: The Pathways Study. a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61:1042–1049, 2004c
Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP: Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 66:316–322, 2004
Kinder LS, Katon WJ, Ludman E, Russo J, Simon G, Lin EHB, Ciechanowski P, Von Korff M, Young B: Improving depression care in patients with diabetes and multiple complications. J Gen Intern Med 21:1036–1041, 2006
Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F: Depression as a risk factor for the onset of type 2 diabetes mellitus: a meta-analysis. Diabetologia 49:837–845, 2006
Kokkonen J, Kokkonen ER: Mental health and social adaptation in young adults with juvenile-onset diabetes. Nord J Psychiatry 49:175–181, 1995
Kovacs M, Obrosky DS, Goldston D, Drash A: Major depressive disorder in youths with IDDM: a controlled prospective study of course and outcome. Diabetes Care 20:45–51, 1997
Kovacs M, Mukerji P, Drash A, Iyengar S: Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care 18:1592–1599, 1995
Kroenke K, Spitzer RL, Williams JBW: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613, 2001
Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese AD, Bell RA, Waitzfelder BE, McKeown RE: Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics 117:1348–1358, 2006
Lin EHB, Katon W, Rutter C, Simon GE, Ludman EJ, Von Korff M, Young B, Oliver M, Ciechanowski PC, Kinder L, Walker E: Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med 4:46–53, 2006
Lustman PJ, Williams MM, Sayuk GS, Nix BD, Clouse RE: Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 30:459–466, 2007
Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB: Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 63:521–529, 2006
Lustman PJ, Clouse RE, Ciechanowski PS, Hirsch IB, Freedland KE: Depression-related hyperglycemia in type 1 diabetes: a mediational approach. Psychosom Med 67:195–199, 2005
Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942, 2000a
Lustman PJ, Freedland KE, Griffith LS, Clouse RE: Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23:618–623, 2000b
Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE: Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 129:613–621, 1998
Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE: Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 59:24–31, 1997a
Lustman PJ Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB: Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250, 1997b
Lustman PJ, Griffith LS, Freedland KE, Clouse RE: The course of major depression in diabetes. Gen Hosp Psychiatry 19:138–143, 1997c
Lustman PJ, Griffith LS, Clouse RE: Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care 11:605–612, 1988
Lustman PJ, Harper GW, Griffith LS, Clouse RE: Use of the Diagnostic Interview Schedule in patients with diabetes mellitus. J Nerv Ment Dis 174:743–746, 1986
McCollum M, Ellis SL, Regensteiner JG, Zhang W, Sullivan PW: Minor depression and health status among